137 related articles for article (PubMed ID: 11401107)
1. Liposomal nystatin (L-NYS) in therapy of pulmonary aspergillosis refractory to conventional amphotericin B in cancer patients.
Krupova Y; Mistrik M; Bojtarova E; Sejnova D; Ilavska I; Krcmery V
Support Care Cancer; 2001 May; 9(3):209-10. PubMed ID: 11401107
[No Abstract] [Full Text] [Related]
2. Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B.
Offner F; Krcmery V; Boogaerts M; Doyen C; Engelhard D; Ribaud P; Cordonnier C; de Pauw B; Durrant S; Marie JP; Moreau P; Guiot H; Samonis G; Sylvester R; Herbrecht R;
Antimicrob Agents Chemother; 2004 Dec; 48(12):4808-12. PubMed ID: 15561860
[TBL] [Abstract][Full Text] [Related]
3. [Medical therapy of pleuro-pulmonary aspergillosis].
Guérin JC; Woehrle R; Kalb JC
J Med Lyon; 1972 May; 53(228):621-2 passim. PubMed ID: 4538887
[No Abstract] [Full Text] [Related]
4. Case reports. Invasive pulmonary aspergillosis in non-neutropenic patients treated with liposomal amphotericin B.
Zhirong Y; Wanqing L; Weihua P
Mycoses; 1999; 42(11-12):679-82. PubMed ID: 10680448
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of bronchopulmonary aspergillosis with antifungal antibiotics].
Leshchenko VM
Antibiotiki; 1972 Dec; 17(12):1103-6. PubMed ID: 4658654
[No Abstract] [Full Text] [Related]
6. Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokinetics.
Groll AH; Gonzalez CE; Giri N; Kligys K; Love W; Peter J; Feuerstein E; Bacher J; Piscitelli SC; Walsh TJ
J Antimicrob Chemother; 1999 Jan; 43(1):95-103. PubMed ID: 10381106
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis.
Gavaldà J; Martín MT; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Puigfel Y; Ruíz I; Pahissa A
Antimicrob Agents Chemother; 2005 Jul; 49(7):3028-30. PubMed ID: 15980392
[TBL] [Abstract][Full Text] [Related]
8. Dose range evaluation of liposomal nystatin and comparisons with amphotericin B and amphotericin B lipid complex in temporarily neutropenic mice infected with an isolate of Aspergillus fumigatus with reduced susceptibility to amphotericin B.
Denning DW; Warn P
Antimicrob Agents Chemother; 1999 Nov; 43(11):2592-9. PubMed ID: 10543734
[TBL] [Abstract][Full Text] [Related]
9. Bilateral pulmonary aspergilloma in ankylosing spondylitis treated with transthoracic intracavitary instillations of antifungal agents.
Stiksa G; Eklundh G; Riebe I; Simonsson BG
Scand J Respir Dis; 1976; 57(4):163-70. PubMed ID: 790560
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin Toxicity.
AORN J; 2017 Jun; 105(6):644-613. PubMed ID: 28554362
[No Abstract] [Full Text] [Related]
11. Safety and efficacy of multilamellar liposomal nystatin against disseminated candidiasis in persistently neutropenic rabbits.
Groll AH; Petraitis V; Petraitiene R; Field-Ridley A; Calendario M; Bacher J; Piscitelli SC; Walsh TJ
Antimicrob Agents Chemother; 1999 Oct; 43(10):2463-7. PubMed ID: 10508025
[TBL] [Abstract][Full Text] [Related]
12. Quiz page. Invasive pulmonary aspergillosis presenting with a pulmonary nodule, pneumomediastinum, pneumothorax, and pneumopericardium.
Sengul S; Keven K; Kutlay S; Ergun I; Azap A; Erbay B
Am J Kidney Dis; 2004 Oct; 44(4):A47, E47-9. PubMed ID: 15384032
[No Abstract] [Full Text] [Related]
13. Medical treatment of pulmonary aspergilloma.
Ikemoto H
Intern Med; 2000 Mar; 39(3):191-2. PubMed ID: 10772117
[No Abstract] [Full Text] [Related]
14. Long-circulating immunoliposomal amphotericin B against invasive pulmonary aspergillosis in mice.
Otsubo T; Maruyama K; Maesaki S; Miyazaki Y; Tanaka E; Takizawa T; Moribe K; Tomono K; Tashiro T; Kohno S
Antimicrob Agents Chemother; 1998 Jan; 42(1):40-4. PubMed ID: 9449258
[TBL] [Abstract][Full Text] [Related]
15. Treatment of invasive pulmonary aspergillosis in severely neutropenic children with malignant disorders using liposomal amphotericin B (AmBisome), granulocyte colony-stimulating factor, and surgery: report of five cases.
Dornbusch HJ; Urban CE; Pinter H; Ginter G; Fotter R; Becker H; Miorini T; Berghold C
Pediatr Hematol Oncol; 1995; 12(6):577-86. PubMed ID: 8589003
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary aspergillosis in mice: treatment with a new triazole SCH39304.
Defaveri J; Salazar MH; Rinaldi MG; Graybill JR
Am Rev Respir Dis; 1990 Sep; 142(3):512-5. PubMed ID: 2202244
[TBL] [Abstract][Full Text] [Related]
17. [Two cases of pulmonary aspergillosis successfully treated with multidrug therapy].
Anndo T
Jpn J Antibiot; 2000 Feb; 53(2):84-90; dicussion 90. PubMed ID: 10896540
[No Abstract] [Full Text] [Related]
18. [Curative antifungal treatment of invasive pulmonary aspergillosis].
Andrès E; Courouau F; Kurtz JE; Limacher JM; Quoix E
Rev Pneumol Clin; 1995; 51(4):228-31. PubMed ID: 7501940
[TBL] [Abstract][Full Text] [Related]
19. Liposomal amphotericin B can safely be administered in paediatric outpatients with cancer for the primary or secondary prevention of invasive aspergillosis.
Simon A; Bode U; Maul M; Fleischhack G
Acta Haematol; 2007; 118(2):68-9. PubMed ID: 17538246
[No Abstract] [Full Text] [Related]
20. [Therapy of pulmonary mycoses].
Schaberg T; Lode H
Dtsch Med Wochenschr; 1992 Nov; 117(45):1725-9. PubMed ID: 1330477
[No Abstract] [Full Text] [Related]
[Next] [New Search]
